Literature Screening in pharmacovigilance is a critical process that involves the systematic review of scientific and medical literature to identify individual case safety reports (ICSRs) and any new information that could impact the safety and efficacy of medicinal products.

This process is essential for Marketing Authorisation Holders (MAHs) in the European Economic Area (EEA) to remain compliant with EU legal requirements and to ensure the ongoing safety monitoring of their medicines.

At Arithmos, we offer a comprehensive Literature Screening service that leverages AI-validated platforms to monitor both international and local scientific literature.

Our state-of-the-art scientific literature monitoring platform enhances the efficiency of reporting and simplifies the Medical Literature Monitoring process.

Our Literature Screening service provides you with the following advantages: